Physician profile
Christopher Davis
NPI 1639609951
$1,716.93
in general payments reported to CMS, 2019-2025
12 companies · $942 in 2025
The $942 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $311 · 2023: $279 · 2024: $184 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $370.33 | 2023-2025 | Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $323.47 | 2022-2025 | Embold Fibered, Epic Vascular |
| Penumbra, INC. | $267.48 | 2025 | Indigo System |
| Stratus Medical, LLC | $189.75 | 2023 | Nimbus |
| Medtronic, INC. | $148.25 | 2022 | |
| Okami Medical, INC. | $143.00 | 2025 | Lobo |
| Sirtex Medical INC | $125.88 | 2025 | Sir-Spheres Microspheres |
| Terumo Medical Corporation | $38.50 | 2023 | Glidesheath Slender, Navicross, Hydropearl |
| Inari Medical, INC. | $37.35 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Siemens Medical Solutions USA, INC. | $28.37 | 2025 | Embozene |
| Becton, Dickinson and Company | $23.87 | 2025 | Rotarexs 6 F X 135 Cm |
| Surmodics, INC. | $20.68 | 2025 | Pounce Thrombectomy, Pounce Xl Thrombectomy, Pounce Venous Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.